ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Materials

ATMI Sells Bioreactor Business To Pall

by Michael McCoy
January 6, 2014 | APPEARED IN VOLUME 92, ISSUE 1

[+]Enlarge
Credit: ATMI
ATMI creates its bioreactors out of high-purity films.
09201-buscon-atmifilmcxd.jpg
Credit: ATMI
ATMI creates its bioreactors out of high-purity films.

ATMI has agreed to sell its business in single-use plastic bioreactors to Pall Corp. for $185 million. The sale includes two locations in Belgium plus a shared facility in Minnesota. ATMI, largely a manufacturer of chemicals for the electronics industry, entered the bioreactor business in 2006 based on its expertise in extruding ultrapure plastic film. The unit had $36 million in sales in the first nine months of 2013. Pall says the new business will complement the filtration, separation, and purification equipment it already sells to the biopharmaceutical industry.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment